Factors associated with the failure of the neuroprotector therapies in the clinical phase of animal models with cerebral ischemia
The strokes have been considered, worldwide, as the third cause of death and the first cause of disability. To diminish the incidence of ischemia cases or cerebral hemorrhage, as well as their consequences, one should have the knowledge on this clinical entities, the associated risk factors and prev...
Saved in:
Main Authors: | Javier Enrique Almenares Rosales (Author), Amanda Moya Gómez (Author), Lena Pérez Font (Author) |
---|---|
Format: | Book |
Published: |
Centro Provincial de Información de Ciencias Médicas,
2021-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of the Search for Neuroprotectors among Bioflavonoids
by: Igor Belenichev, et al.
Published: (2024) -
POSSIBILITIES OF COMBINATIONAL MAGNESIAL AND NEUROPROTECTOR THERAPY IN PATIENTS WITH EARLY CEREBROVASCULAR PATHOLOGY
by: E.I. Gusev, et al.
Published: (2007) -
POSSIBILITIES OF COMBINATIONAL MAGNESIAL AND NEUROPROTECTOR THERAPY IN PATIENTS WITH EARLY CEREBROVASCULAR PATHOLOGY
by: E.I. Gusev, et al.
Published: (2007) -
Pharmacological properties of selenium and its preparations: from antioxidant to neuroprotector
by: Igor F. Belenichev, et al.
Published: (2021) -
Thiouronium Salt Derivatives Based on Vicinal Diamines as Potential Neuroprotectors
by: N. A. Lozinskaya, et al.
Published: (2023)